These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2905952)

  • 41. Dopamine receptor affinities in vitro and neurochemical effects in vivo of pergolide and its metabolites.
    Wong DT; Threlkeld PG; Bymaster FP
    Arzneimittelforschung; 1993 Apr; 43(4):409-12. PubMed ID: 7684223
    [TBL] [Abstract][Full Text] [Related]  

  • 42. SCH 23390 may alter dopamine-mediated motor behaviour via striatal D-1 receptors.
    Boyce S; Kelly E; Davis A; Fleminger S; Jenner P; Marsden CD
    Biochem Pharmacol; 1985 May; 34(10):1665-9. PubMed ID: 2988552
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Behavioral sensitization to beta-phenylethylamine (PEA): enduring modifications of specific dopaminergic neuron systems in the rat.
    Kuroki T; Tsutsumi T; Hirano M; Matsumoto T; Tatebayashi Y; Nishiyama K; Uchimura H; Shiraishi A; Nakahara T; Nakamura K
    Psychopharmacology (Berl); 1990; 102(1):5-10. PubMed ID: 2392508
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vivo studies of striatal dopamine release and metabolism following administration of L-dopa.
    Brannan T; Knott P; Kaufmann H; Yahr M
    Adv Neurol; 1990; 53():75-81. PubMed ID: 2173378
    [No Abstract]   [Full Text] [Related]  

  • 45. An investigation of the relationship between the dopaminergic and electroencephalographic effects of gamma-butyrolactone.
    Snead OC
    Neuropharmacology; 1982 Jun; 21(6):539-43. PubMed ID: 7110537
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 5-HT loss in rat brain by type II pyrethroid insecticides.
    Martinez-Larrañaga MR; Anadón A; Martínez MA; Martínez M; Castellano VJ; Díaz MJ
    Toxicol Ind Health; 2003 Oct; 19(7-10):147-55. PubMed ID: 15747775
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of cyclo (Leu-Gly) on neurochemical indices of striatal dopaminergic supersensitivity induced by prolonged haloperidol treatment.
    Le Douarin C; Fage D; Scatton B
    Life Sci; 1984 Jan; 34(4):393-9. PubMed ID: 6694528
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of monoamine oxidase-B by (-)-deprenyl potentiates neuronal responses to dopamine agonists but does not inhibit dopamine catabolism in the rat striatum.
    Paterson IA; Juorio AV; Berry MD; Zhu MY
    J Pharmacol Exp Ther; 1991 Sep; 258(3):1019-26. PubMed ID: 1679846
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dopaminergic mediation of beta-endorphin-induced catalepsy.
    Van Loon GR; Kim C
    Res Commun Chem Pathol Pharmacol; 1978 Jul; 21(1):37-44. PubMed ID: 567367
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential changes in DOPAC levels in the hippocampal formation, septum and striatum of the rat induced by acute and repeated neuroleptic treatment.
    Scatton B
    Eur J Pharmacol; 1981 May; 71(4):499-503. PubMed ID: 6113973
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of long-term administration of 1,2,3,4-tetrahydroisoquinoline (TIQ) on striatal dopamine and 3,4-dihydroxyphenylacetic acid (DOPAC) content in mice.
    Saitoh T; Mizuno Y; Nagatsu T; Yoshida M
    Neurosci Lett; 1988 Oct; 92(3):321-4. PubMed ID: 3200488
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Voltammetry in unanesthetized rat: increases of striatal dopamine turnover after unilateral haloperidol injection into the substantia nigra.
    Kato T; Ishii K; Ikeda M
    Neurosci Lett; 1984 Sep; 50(1-3):263-7. PubMed ID: 6493630
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Influence of pyrethroids and piperonyl butoxide on histamine release from isolated rat mast cells.
    Grosman N
    Inflamm Res; 2007 Nov; 56(11):473-8. PubMed ID: 17891335
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of permethrin, cypermethrin and 3-phenoxybenzoic acid on rat sperm motility in vitro evaluated with computer-assisted sperm analysis.
    Yuan C; Wang C; Gao SQ; Kong TT; Chen L; Li XF; Song L; Wang YB
    Toxicol In Vitro; 2010 Mar; 24(2):382-6. PubMed ID: 19896529
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Altered behavioral response to a D2 agonist, LY141865, in spontaneously hypertensive rats exhibiting biochemical and endocrine responses similar to those in normotensive rats.
    Fuller RW; Hemrick-Luecke SK; Wong DT; Pearson D; Threlkeld PG; Hynes MD
    J Pharmacol Exp Ther; 1983 Nov; 227(2):354-9. PubMed ID: 6138425
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Involvement of cholecystokinin receptors in the control of striatal dopamine autoreceptors.
    Tanganelli S; Fuxe K; von Euler G; Agnati LF; Ferraro L; Ungerstedt U
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Sep; 342(3):300-4. PubMed ID: 2280797
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Induction of cytochrome P450 2B1 by pyrethroids in primary rat hepatocyte cultures.
    Heder AF; Hirsch-Ernst KI; Bauer D; Kahl GF; Desel H
    Biochem Pharmacol; 2001 Jul; 62(1):71-9. PubMed ID: 11377398
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Modifications of striatal D2 dopaminergic postsynaptic sensitivity during development of morphine tolerance-dependence in mice.
    Navarro M; Fernández-Ruiz JJ; Rodriguez de Fonseca F; Hernández ML; Cebeira M; Ramos JA
    Pharmacol Biochem Behav; 1992 Oct; 43(2):603-8. PubMed ID: 1332081
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neurochemical and behavioral effects of acute and chronic treatment with apomorphine in rats.
    Rowlett JK; Mattingly BA; Bardo MT
    Neuropharmacology; 1991 Feb; 30(2):191-7. PubMed ID: 1903190
    [TBL] [Abstract][Full Text] [Related]  

  • 60. On the mechanism which mediates the effects of long-term administration of fencamfamine in rats.
    Planeta CS; DeLucia R; Aizenstein ML; Scavone C
    Braz J Med Biol Res; 1989; 22(7):881-3. PubMed ID: 2576524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.